You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Neonates and infants have been referred to as ‘therapeutic orphans’ due to the overall scarcity of treatments that have been developed and tailored to their needs. However, in recent years there have been increased efforts by researchers and regulatory bodies to focus on the provision of drugs, devices, and treatment modalities tailored for pediatric use. This trend is also being witnessed in neonatology, but a lot more needs to be done. This Research Topic aims to capture the latest research, reviews, and scientific opinion on new drugs, devices, diagnostics, monitoring modalities, and therapeutic models in neonatology. This includes specific products like drugs and medical devices used in the ‘detection, monitoring or management of various neonatal conditions’ such as; - Bronchopulmonary dysplasia - Neonatal seizures - Malabsorption and poor growth - Necrotizing enterocolitis - Hypoxic-ischemic encephalopathy - Retinopathy of prematurity - Pediatric short bowel syndrome - Respiratory distress syndrome - Congenital hyperinsulinism - Neonatal infections and Sepsis
Preterm birth affects over 15 million newborns worldwide each year and is the main contributor of neonatal mortality and morbidity. While neonatal survival following preterm birth continues to improve, this has not been matched by a decline in neurological outcome. There is still a high prevalence of motor problems, executive dysfunction, and cognitive impairment in infants born preterm. Improved neuroimaging has helped to describe different types of neonatal brain injuries in this population and has given a better understanding of underlying pathogenesis. However, therapies are still lacking and there is a great need to find novel strategies to improve injury and functional outcome.
None
None